/People

Dennis Henriksen

Investor

Partner at Ventac Partners

Copenhagen, Denmark

Writes $100K – $5M checks · typically $1.5M

Find your path to Dennis

193 people in our graph can introduce you to Dennis.

Each arrow is one introduction. Sign up to fill in the first one.

Ask Lasse Richter Petersen to introduce you to Dennis

You →Lasse · together at Cenexum (2022–2026) →Dennis

Ask Jamie Chen to introduce you to Dennis

You →Jamie · 2 people · together at Cenexum →Dennis

Ask Sam Okafor to introduce you to Dennis

You →Sam · 8 people · together at Ventac Partners →Dennis

Sign up to find every way you can get introduced to Dennis

  • Your email: the people you already email who know Dennis
  • 2nd- and 3rd-degree connections: people you know who worked, studied or invested with Dennis
  • Your LinkedIn: the connections who can make the intro for you

We rank every route by how warm it is, so you raise on warm intros instead of cold emails.

About

Dennis Henriksen is a partner at Ventac Partners and chief executive officer at Cenexum. He is a bioorganic chemist with over 25 years of experience in pharmaceutical biotechnology, including roles in drug discovery, research and development, pilot plant production for clinical trials, clinical trial management, and business development. His background spans scientific and operational functions across the pharmaceutical biotechnology industry.

Experience

  1. CenexumChief Executive Officercurrent2022 — presentAarhus Municipality, Central Denmark Region, Denmark
  2. Ventac PartnersPartnercurrent2014 — presentCopenhagen Metropolitan Area
  3. DBH BIONManaging Partnercurrent2012 — presentCopenhagen Metropolitan Area
  4. WntResearch ABCTO2015 — 2025Greater Malmö Metropolitan Area
  5. Idogen ABChief Technology Officer2015 — 2023Kalmar County, Sweden
  6. Avexxin ASHead of CMC2014 — 2019Trondheim, Trøndelag, Norway
  7. Sanos BioscienceCEO2004 — 2011Copenhagen Metropolitan Area
  8. Nordic BioscienceVP R&D1998 — 2003Copenhagen Metropolitan Area
  9. Verigen Europe A/SCOO1998Copenhagen Metropolitan Area
  10. BIONVP1997Copenhagen Metropolitan Area
  11. BioNebraska Inc,VP R&D1993 — 1996Lincoln, Nebraska Metropolitan Area

Skills & more

Drug Discovery24Diagnostics1Clinical Trials9Clinical Development19Osteoporosis4Protein Chemistry4Biotechnology24R&D14Life Sciences9Biomarkers1Biopharmaceuticals9Technology Transfer3
+12 moreIntellectual PropertyProcess DevelopmentStart-upsClinicalBusiness StrategyProduct DevelopmentStrategic PlanningGMPLeadershipCTMSClinical ResearchDrug Development

Languages English

From Dennis's professional profile.

Colleagues at Ventac Partners

Network4

Investors connected to Dennis in public investor directories — a warm-intro map.

Frequently asked questions

Who is Dennis Henriksen?
Dennis Henriksen is a partner at Ventac Partners and chief executive officer at Cenexum. He is a bioorganic chemist with over 25 years of experience in pharmaceutical biotechnology, including roles in drug discovery, research and development, pilot plant production for clinical trials, clinical trial management, and business development. His background spans scientific and operational functions across the pharmaceutical biotechnology industry.
Where does Dennis Henriksen work?
Dennis Henriksen is Partner at Ventac Partners.
What check size does Dennis Henriksen write?
Dennis Henriksen typically writes checks of $100K – $5M.
Where did Dennis Henriksen go to school?
Dennis Henriksen studied at University of Copenhagen (Ph.D. Degree, Bioorganic Chemistry); The Technical University of (M.Sc, Chemical Engineering).

Same school

Shared employers